Professor Bill Sessa, Former Chief Scientific Officer of Internal Medicine at Pfizer, Appointed Chair of Isomab's Scientific Advisory Board

Summary

Isomab announces appointment of Professor Bill Sessa, former Chief Scientific Officer at Pfizer, as Chair of its Scientific Advisory Board, joined by leading vascular biologists to advise on development of ISM-001, a first-in-class anti-VEGF-A165b antibody for chronic angina.